Search research articles
Contact Us
Filters
Showing results (121-130 of 150) with videos related to
Page
of 15
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
August 23, 2017
Metabolic activity by <sup>18</sup>F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
Kyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse, et al.
International Cancer Conference Journal
|
January 27, 2026
Acute esophageal mucosal injury during pembrolizumab treatment after a hypopharyngeal cancer patient's free jejunal autograft reconstruction, as an immune-related adverse event
Yuten Shuri, Kenji Nakano, Koichi Takeda, et al.
Cancer Science
|
October 23, 2024
FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor
Suguru Maruyama, Yu Imamura, Tasuku Toihata, et al.
Cancer Immunology Research
|
May 20, 2016
Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients
Kohei Tada, Shigehisa Kitano, Hirokazu Shoji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2022
Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors
Jun Sato, Toshio Shimizu, Takafumi Koyama, et al.
International Journal of Hematology
|
March 25, 2025
Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host disease
Yoshihiro Inamoto, Ayumu Ito, Toshihisa Nakashima, et al.
Vaccine
|
September 19, 2009
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432
Masatoshi Aoki, Shugo Ueda, Hiroyoshi Nishikawa, et al.
Cancer Immunology Research
|
January 14, 2014
Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor
Margaret K Callahan, Gregg Masters, Christine A Pratilas, et al.
Therapeutic Advances in Medical Oncology
|
September 15, 2025
Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)
Hiroki Osumi, Takeru Wakatsuki, Akira Ooki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan
Shigehisa Kitano, Shinichi Kageyama, Yasuhiro Nagata, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 150) with videos related to
Sort By:
Page
of 15
European Journal of Nuclear Medicine and Molecular Imaging
|
August 23, 2017
Metabolic activity by <sup>18</sup>F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
Kyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse, et al.
International Cancer Conference Journal
|
January 27, 2026
Acute esophageal mucosal injury during pembrolizumab treatment after a hypopharyngeal cancer patient's free jejunal autograft reconstruction, as an immune-related adverse event
Yuten Shuri, Kenji Nakano, Koichi Takeda, et al.
Cancer Science
|
October 23, 2024
FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor
Suguru Maruyama, Yu Imamura, Tasuku Toihata, et al.
Cancer Immunology Research
|
May 20, 2016
Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients
Kohei Tada, Shigehisa Kitano, Hirokazu Shoji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2022
Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors
Jun Sato, Toshio Shimizu, Takafumi Koyama, et al.
International Journal of Hematology
|
March 25, 2025
Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host disease
Yoshihiro Inamoto, Ayumu Ito, Toshihisa Nakashima, et al.
Vaccine
|
September 19, 2009
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432
Masatoshi Aoki, Shugo Ueda, Hiroyoshi Nishikawa, et al.
Cancer Immunology Research
|
January 14, 2014
Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor
Margaret K Callahan, Gregg Masters, Christine A Pratilas, et al.
Therapeutic Advances in Medical Oncology
|
September 15, 2025
Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)
Hiroki Osumi, Takeru Wakatsuki, Akira Ooki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan
Shigehisa Kitano, Shinichi Kageyama, Yasuhiro Nagata, et al.
Page
of 15